Tag "3"

Novartis blocked from selling Neupogen copycat until Sept 2

By Andrew Chung NEW YORK (Reuters) – Novartis AG unit Sandoz must wait until Sept. 2 to sell Zarxio, the first biosimilar drug to be approved in the United States and a copycat version of Amgen Inc’s $1.2 billion-a-year anti-infection drug Neupogen, a U.S. appeals court said on Tuesday. The ruling stemmed from a lawsuit that Amgen filed last October in federal court in San Francisco in which it accused

Kids with psychiatric problems may face struggles as adults

By Lisa Rapaport (Reuters Health) – Kids with psychiatric problems may be more likely to have health, legal, financial and social difficulties as adults even when their mental health issues don’t persist beyond childhood, a study suggests. Researchers tracked 1,420 kids between ages nine and 16, assessing them on up to six occasions for common psychiatric diagnoses as well as mental health problems that didn’t rise to the level of